{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:32:05Z","timestamp":1776274325809,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jchromb.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T12:47:25Z","timestamp":1490359645000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates"],"prefix":"10.1016","volume":"1052","author":[{"given":"Andrew J.","family":"Ocque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen E.","family":"Hagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"DiFrancesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene D.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Talal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2017.03.020_bib0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.13514","article-title":"Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy","volume":"43","author":"Banerjee","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.jchromb.2017.03.020_bib0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cmi.2016.05.027","article-title":"Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice","volume":"22","author":"Arends","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0015","series-title":"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version","year":"2016"},{"key":"10.1016\/j.jchromb.2017.03.020_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jchromb.2017.03.020_bib0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group","volume":"321","author":"Davis","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1208\/s12248-015-9846-1","article-title":"Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir, and ribavirin in patients with hepatitis C virus genotype 1 infection: combined analysis from 9 phase 1b\/2 studies","volume":"18","author":"Mensing","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2015.03.029","article-title":"Ombitasvir\/paritaprevir\/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine","volume":"63","author":"Lalezari","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1124\/dmd.115.067512","article-title":"Metabolism and disposition of hepatitis C polymerase inhibitor dasabuvir in humans","volume":"44","author":"Shen","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bcp.12873","article-title":"Pharmacokinetics and tolerability of paritaprevir a direct acting antiviral agent for hepatitis C virus treatment, with and without ritonavir in healthy volunteers","volume":"81","author":"Menon","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0050","series-title":"Perscribing Information VIEKIRA PAK, DOI","author":"AbbVie Corporation","year":"2016"},{"key":"10.1016\/j.jchromb.2017.03.020_bib0055","first-page":"2","article-title":"Fine needle aspiration in the diagnosis of liver neoplasms: a review","volume":"21","author":"Houn","year":"1991","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jvh.12213","article-title":"Gene expression analysis in serial liver fine needle aspirates","volume":"22","author":"Lejnine","year":"2015","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4155\/bio-2016-0040","article-title":"Development and validation of a UPLC-MS\/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver","volume":"8","author":"Ocque","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.03.020_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpba.2016.04.031","article-title":"A UHPLC-MS\/MS method for the quantification of direct antiviral agents simeprevir daclatasvir, ledipasvir, sofosbuvir\/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma","volume":"125","author":"Ariaudo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0075","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2017.03.020_bib0080","series-title":"Department of Health and Human Services, Guidance for Industry Bioanalytical Method Validation","author":"U.S. Food and Drug Administration (FDA)","year":"2001"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T03:25:34Z","timestamp":1535945134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":16,"alternative-id":["S1570023217300272"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.03.020","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}